Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
Clinical trial NCT00670774 · COMPLETED
Trial details
- NCT number
- NCT00670774
- Sponsor
- Mark Stegall
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2017-05-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.